Illumina Ventures
The leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation as we accelerate the impact on human health.
Company Size
6 - 10 employees
Year Founded
2016
About Illumina Ventures
We are the premier genomics and precision health venture firm supporting early-stage companies to improve human health.
Independently managed, we bring depth of knowledge, decades of domain expertise, strong operating experience, and a strategic relationship with Illumina (NASDAQ: ILMN). This enables us to identify and build companies that will transform healthcare and our world. We operate as true partners to entrepreneurs developing breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, we accelerate value creation for early-stage genomics start-ups via access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.
